Back to top
more

Veeva Systems (VEEV)

(Delayed Data from NYSE)

$215.48 USD

215.48
891,919

+0.68 (0.32%)

Updated Sep 18, 2024 04:00 PM ET

After-Market: $216.20 +0.72 (0.33%) 6:52 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 30% (74 out of 250)

Industry: Internet - Software

Better trading starts here.

Zacks News

Varian Medical's (VAR) ProBeam Compact Picked by Biopolis

The development is likely to boost Varian Medical's (VAR) Proton business that declined 12% year over year in the last reported quarter.

ResMed Launches Nasal Mask Devise, Extends AirFit Portfolio

ResMed's (RMD) AirFit N30i with a top-of-head connection keeps tubing out of the wearers' way, thus letting them conveniently move and sleep in any position.

CVS Health's PBM Pharmacy Platform to Ride on Walmart Deal

Per the terms of the deal between CVS Health (CVS) and Walmart, the latter will continue to take part in the CVS Caremark PBM commercial and Managed Medicaid retail pharmacy networks.

Quest Diagnostics' Core Diagnostics Strong Amid Several Woes

Quest Diagnostics' (DGX) steady efforts to intensify focus on core diagnostic information services business and an intelligent capital management give investors ample reasons to cheer for.

Neogen Gains on Strong Genomic Arm Amid Stiff Competition

Neogen's (NEOG) genomic business shows steady growth on acquisitions in Australia and Brazil. Stiff rivalry a cause of concern.

The Zacks Analyst Blog Highlights: Veeva, Attunity, Microsoft, Cloudera and Facebook

The Zacks Analyst Blog Highlights: Veeva, Attunity, Microsoft, Cloudera and Facebook

Can Medical Devices Strength Drive Abbott (ABT) Q4 Earnings?

Abbott (ABT) Q4 results likely to show continued growth in Medical Devices business.

Here's Why You Should Buy Myriad Genetics (MYGN) Stock Now

On the success of the Elevate 2020 program, along with augmenting reimbursements for tests, Myriad Genetics (MYGN) seems to be well-positioned to deliver strong financial results in fiscal 2019.

Baxter (BAX) Gains From Sharesource's Global Success Rates

Baxter's (BAX) PD platform sees increased demand, owing to rising CKD rates around the world.

Here's Why Investors Should Hold AngioDynamics (ANGO) Now

AngioDynamics' (ANGO) flagship NanoKnife System is currently witnessing robust demand.

Cerner Picked by Remi Vista for Behavioral Health Technology

Apart from Cerner Integrated, Cerner's (CERN) revenue cycle solutions will help Remi Vista's financial operations.

Ryan McQueeney headshot

3 Cloud Stocks to Buy Right Now

In a matter of just a few years, "the Cloud" has evolved from a budding new tech feature to one of the main factors driving growth in the technology sector. With this in mind, we've highlighted three stocks that are showing strong cloud-related activity. Check out these three cloud stocks to buy right now!

Here's Why Investors Should Retain athenahealth (ATHN) Stock

athenahealth (ATHN) gains from a broad product portfolio. However, it faces stiff competition in the MedTech space.

Henry Schein Animal Health Spin-Off Approaches, Cost Mounts

Henry Schein's (HSIC) animal health spin-off will help it boost growth opportunities in dental space to deliver quality clinical care plus advanced wellness and prevention.

Allscripts Selected by Premier for Connected Health Platform

Premier Orthopaedics will leverage on Allscripts' (MDRX) Professional EHR, Practice Management software, FollowMyHealth and Payerpath suite of solutions.

Veeva Systems (VEEV) Outpaces Stock Market Gains: What You Should Know

Veeva Systems (VEEV) closed the most recent trading day at $101.66, moving +0.26% from the previous trading session.

Why You Should Consider Buying Omnicell (OMCL) Stock Now

Omnicell (OMCL) is pulling out all the stops to strengthen the medication adherence segment.

Here's Why You Should Invest in OPKO Health (OPK) Right Now

OPKO Health's (OPK) flagship RAYALDEE lends it a competitive edge in the MedTech space.

Here's Why Investors Should Hold Patterson Companies Stock

Patterson Companies (PDCO) gains from solid foothold in theAnimals Health business. However, the company is facing headwinds in the Dental segment.

Oracle at NRF 2019: One Door Tie-Up, Growing Retail Clientele

Oracle (ORCL) is raising the bar in digital commerce with new collaborations. Moreover, Oracle Retail services are witnessing traction.

QIAGEN QFT-Plus Ok'd in Canada, Test Customer Base Expands

QIAGEN (QGEN) progresses with plans to widen customer base for QuantiFERON-TB Gold Plus test.

Here's Why Investors Should Hold McKesson (MCK) Stock Now

McKesson (MCK) gains traction from a solid foothold in the pharmaceutical and medical supplies distribution market. However, the company is grappled with regulatory constraints in Canada.

Oracle Ups Ante in Digital Commerce with New Retail Services

Oracle (ORCL) ramps up Retail Omnichannel product suite at NRF 2019, in a bid to enable retailers to provide customers with improved shopping experience.

IBM to Reportedly Buy T-Systems' Mainframe Business Unit

IBM (IBM) is reportedly buying mainframe service business of T-Systems amid cash crunch to capitalize on the growth prospects in the domain.

Cerner & Christiana Care Unite to Offer Bariatric Services

Cerner (CERN) likely to gain from increased obesity rates in the United States.